Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Research Articles

IL4 Limits the Efficacy of Tumor-Targeted Antibody Therapy in a Murine Model

Rishi Surana, Shangzi Wang, Wei Xu, Sandra A. Jablonski and Louis M. Weiner
Rishi Surana
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shangzi Wang
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Xu
Department of Pathology, Georgetown University Medical Center, Washington, District of Columbia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra A. Jablonski
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louis M. Weiner
Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: weinerl@georgetown.edu
DOI: 10.1158/2326-6066.CIR-14-0103 Published November 2014
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: September 2014 to December 2019

AbstractFull-text HTMLPDF
Total20991074812

Cited By

Article Information

Volume 2, Issue 11, pp. 1103-1112

DOI 
https://doi.org/10.1158/2326-6066.CIR-14-0103
PubMed 
25204776

Published By 
American Association for Cancer Research
Print ISSN 
2326-6066
Online ISSN 
2326-6074
History 
  • Received May 28, 2014
  • Revision received July 28, 2014
  • Accepted August 26, 2014
  • Published first September 9, 2014.

Article Versions

  • Previous version (September 9, 2014 - 06:03).
  • Previous version (September 18, 2014 - 05:26).
  • Previous version (October 15, 2014 - 08:02).
  • You are viewing the most recent version of this article.
Copyright & Usage 
©2014 American Association for Cancer Research.

Author Information

  1. Rishi Surana1,
  2. Shangzi Wang1,
  3. Wei Xu2,
  4. Sandra A. Jablonski1, and
  5. Louis M. Weiner1,*
  1. 1Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia.
  2. 2Department of Pathology, Georgetown University Medical Center, Washington, District of Columbia.
  1. ↵*Corresponding Author:
    Louis M. Weiner, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3970 Reservoir Road, NW, Washington, DC 20057. Phone: 202-687-2110; Fax: 202-687-6402; E-mail: weinerl{at}georgetown.edu
View Full Text
PreviousNext
Back to top
Cancer Immunology Research: 2 (11)
November 2014
Volume 2, Issue 11
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
IL4 Limits the Efficacy of Tumor-Targeted Antibody Therapy in a Murine Model
(Your Name) has forwarded a page to you from Cancer Immunology Research
(Your Name) thought you would be interested in this article in Cancer Immunology Research.
Citation Tools
IL4 Limits the Efficacy of Tumor-Targeted Antibody Therapy in a Murine Model
Rishi Surana, Shangzi Wang, Wei Xu, Sandra A. Jablonski and Louis M. Weiner
Cancer Immunol Res November 1 2014 (2) (11) 1103-1112; DOI: 10.1158/2326-6066.CIR-14-0103

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
IL4 Limits the Efficacy of Tumor-Targeted Antibody Therapy in a Murine Model
Rishi Surana, Shangzi Wang, Wei Xu, Sandra A. Jablonski and Louis M. Weiner
Cancer Immunol Res November 1 2014 (2) (11) 1103-1112; DOI: 10.1158/2326-6066.CIR-14-0103
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Engineering Therapeutic TCRs
  • Chemotherapy Improves Anti–PD-1 in MSS Colorectal Cancer
  • Immune Microenvironment and Chemosensitivity Signature
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement